Purchasers Win Cert. Again In Blood Test Antitrust MDL

Law360, Los Angeles (October 19, 2015, 10:53 PM EDT) -- A Pennsylvania federal judge on Monday recertified a class of buyers of reagents used in blood tests in multidistrict litigation alleging that a former Johnson & Johnson unit conspired with another company to fix prices on the reagents.

U.S. District Judge Jan E. DuBois decided that an expert’s methodologies for calculating classwide damages survived a Daubert analysis because he had reliably estimated the alleged overcharge in a supposed scheme between former J&J unit Ortho-Clinical Diagnostics Inc. — now owned by the Carlyle Group — and Immucor...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.